Point72 Asia Singapore Pte. Ltd. Sells 34,385 Shares of Enhabit, Inc. (NYSE:EHAB)

Point72 Asia Singapore Pte. Ltd. lessened its holdings in shares of Enhabit, Inc. (NYSE:EHAB - Free Report) by 49.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 35,024 shares of the company's stock after selling 34,385 shares during the quarter. Point72 Asia Singapore Pte. Ltd. owned approximately 0.07% of Enhabit worth $274,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently modified their holdings of the business. 8 Knots Management LLC boosted its holdings in Enhabit by 16.4% in the 4th quarter. 8 Knots Management LLC now owns 4,430,898 shares of the company's stock worth $34,605,000 after buying an additional 623,602 shares during the period. D. E. Shaw & Co. Inc. boosted its stake in shares of Enhabit by 33.2% in the fourth quarter. D. E. Shaw & Co. Inc. now owns 1,004,215 shares of the company's stock worth $7,843,000 after acquiring an additional 250,215 shares during the period. Dimensional Fund Advisors LP grew its position in shares of Enhabit by 12.3% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,953,941 shares of the company's stock worth $15,260,000 after purchasing an additional 213,774 shares in the last quarter. Paradice Investment Management LLC raised its stake in Enhabit by 12.8% during the 4th quarter. Paradice Investment Management LLC now owns 1,780,113 shares of the company's stock valued at $13,903,000 after purchasing an additional 201,997 shares during the period. Finally, Nuveen Asset Management LLC lifted its holdings in Enhabit by 95.5% in the 4th quarter. Nuveen Asset Management LLC now owns 265,361 shares of the company's stock worth $2,072,000 after purchasing an additional 129,610 shares in the last quarter.

Enhabit Price Performance

Shares of EHAB traded down $0.23 during midday trading on Wednesday, hitting $10.39. 76,551 shares of the company traded hands, compared to its average volume of 458,990. The stock has a market cap of $525.87 million, a price-to-earnings ratio of -4.47 and a beta of 1.61. The firm has a 50 day moving average of $8.62 and a 200-day moving average of $8.25. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.46 and a current ratio of 1.46. Enhabit, Inc. has a 52 week low of $6.85 and a 52 week high of $10.79.

Enhabit (NYSE:EHAB - Get Free Report) last posted its earnings results on Wednesday, May 7th. The company reported $0.10 EPS for the quarter, topping analysts' consensus estimates of $0.07 by $0.03. The company had revenue of $259.90 million for the quarter, compared to the consensus estimate of $266.11 million. Enhabit had a positive return on equity of 1.67% and a negative net margin of 11.24%. On average, analysts forecast that Enhabit, Inc. will post 0.22 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Separately, Jefferies Financial Group restated a "buy" rating on shares of Enhabit in a research note on Thursday, March 6th.

Enhabit Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.